Drug intelligence / Profile preview

Desquam-E

Development stage: Unknown
Modality: Small Molecules
Administration: Topical

Overview

Desquam-E is a **topical benzoyl peroxide dermatologic product** used primarily for the treatment of mild to moderate acne vulgaris, with some topical presentations also used for rosacea. Benzoyl peroxide is a **small-molecule oxidizing antimicrobial and keratolytic agent** that reduces *Cutibacterium acnes* burden and promotes epidermal peeling and drying, helping clear comedonal and inflammatory lesions. Desquam-E has been described in multiple topical dosage forms such as gel, cream, foam, lotion, pads, and sponges for topical administration.

Brand names: Desquam-E

Targets

DNA

Beyond the preview

Go deeper on Desquam-E.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Desquam-E.

Explore the full profile